Fertiparin 40 Injection contains Enoxaparin sodium, a low molecular weight heparin (40mg/0.4ml), used primarily as an anticoagulant to prevent and treat thromboembolic disorders. It works by inhibiting factor Xa and thrombin, thereby reducing blood clot formation. Fertiparin 40 is commonly prescribed for the prevention of deep vein thrombosis (DVT) in patients undergoing surgery, those with restricted mobility, or individuals at high risk of venous thromboembolism. Additionally, it is used in the management of acute coronary syndromes and during dialysis procedures to prevent clotting. The injection is administered subcutaneously, allowing for predictable anticoagulant effects and ease of use without frequent monitoring in most cases. Fertiparin 40 should be used cautiously in patients with bleeding disorders, severe renal impairment, or a history of heparin-induced thrombocytopenia. Common side effects may include bleeding, bruising at the injection site, and rarely, allergic reactions. It is essential to follow the prescribed dosage and administration guidelines to minimize risks. Fertiparin 40 Injection offers an effective and convenient option for anticoagulation therapy, contributing significantly to the prevention and treatment of thrombotic complications in various clinical settings.